en · de · es · fr · pt
semax-notes.peptides6608.com › News › Semax Background And Mechanism — 2026 Update

Semax Background And Mechanism — 2026 Update

By Editorial Desk · published 2025-08-05 · last reviewed 2025-08-28 · News

ACTH(4-10) raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2025-08-28 and is reviewed periodically as new material appears.

Semax Background And Mechanism

The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.

Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.

Semax 的分子背景与结构

研究兴趣主要集中在神经营养因子相关的路径上,包括脑源性神经营养因子与神经生长因子的表达变化。部分实验报告称在特定条件下观察到这些因子的水平上升,但具体信号通路和剂量依赖关系仍未完全厘清。多数公开数据来自细胞模型和动物实验,人体对照研究数量有限。因此,该化合物的作用机制在文献中属于活跃讨论,而非已经确立的定论。

Semax 是一种人工合成的七肽,氨基酸序列为 Met-Glu-His-Phe-Pro-Gly-Pro,单字母缩写记作 MEHFPGP。它被归类为促肾上腺皮质激素片段 ACTH(4-10) 的结构类似物,但并不天然存在于生物体内。母体片段 ACTH(4-10) 的序列为 Met-Glu-His-Phe-Arg-Trp-Gly,Semax 替换了中间两个残基,并在羧基端延长了 Pro-Gly-Pro 三肽。这种延长被普遍认为能提升分子对肽酶的耐受性。

Semax at a glance

PropertyValueNotes
Molecular formulaC37H51N9O10SCalculated for the free peptide
Molar mass813.9 g/molAnhydrous free base
Peptide classSynthetic heptapeptideACTH(4-10) analogue
Parent fragmentACTH(4-10)Adrenocorticotropic hormone segment
Developmental originInstitute of Molecular Genetics, MoscowWork began in the 1980s

Semax Structure and Research Background

Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.

Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.

Related pages on this site

Background and Development History

Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

Semax Origin and Molecular Structure

Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.

Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.

Semax Peptide Structure and Origin

The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.

Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.

Supporting material

The following day, Foreign Minister Sihasak Phuangketkeow was named as Bhumjaithai's second candidate for prime minister as a backup. On 25 December, Pheu Thai announced its list of 500 candidates to contest every House seat. Anutin ruled out any coalition between Bhumjaithai and parties seeking to amend Article 112 on lèse-majesté following statements by Natthaphong that the People's Party would never vote for Anutin to become prime minister again. On 26 December, the Democrat Party announced its three candidates for prime minister: party leader Abhisit Vejjajiva, Korn Chatikavanij, and Karndee Leopairote, at its headquarters in Bangkok. Palang Pracharath Party leader Prawit Wongsuwon announced his intention to retire from politics after withdrawing as one of the party's three prime ministerial candidates. His withdrawal as a prime ministerial candidate was joined by deputy party leader Thirachai Phuvanatnaranubala, who also announced his withdrawal from politics. On 28 December, representatives from 52 political parties registered their parties' lists of prime ministerial and party-list candidates.

== Personnel == Duncan Sheik – vocals, backing vocals, electric piano, harmonium, synthesizers, acoustic guitars, electric guitars Patrick Leonard – acoustic piano, electric piano, synthesizers, organs, Moog bass Gerry Leonard – electric guitars, mandolin, loops, ambiences, backing vocals (3) Jeff Allen – bass Doug Yowell – drums (1, 2, 4–11), percussion Additional musicians

== Research == Metformin is a pleiotropic drug, with extensive off-target activity beyond its antidiabetic effect. Much of this has been attributed to its action on AMP-activated protein kinase (AMPK), although other mechanisms have been proposed. Metformin has been studied for its effects on multiple other conditions, including:

Hydrogen gas is produced in many types of fermentation as a way to regenerate NAD+ from NADH. Electrons are transferred to ferredoxin, which in turn is oxidized by hydrogenase, producing H2. Hydrogen gas is a substrate for methanogens and sulfate reducers, which keep the concentration of hydrogen low and favor the production of such an energy-rich compound, but hydrogen gas at a fairly high concentration can nevertheless be formed, as in flatus. For example, Clostridium pasteurianum ferments glucose to butyrate, acetate, carbon dioxide, and hydrogen gas. The reaction leading to acetate is:

== See also == Bond number – Dimensionless number in fluid dynamicsPages displaying short descriptions of redirect targets Bound water – Thin layer of water surrounding mineral surfaces Capillary action through synthetic mesh Capillary fringe – Subsurface layer in which groundwater seeps up from a water table by capillary action Capillary pressure – Pressure between two fluids from forces between the fluids and tube walls Capillary wave – Wave on the surface of a fluid, dominated by surface tension Capillary bridges – Minimised surface of liquid connecting two wetted objectsPages displaying short descriptions of redirect targets Damp proofing – Type of moisture control in building construction Darcy's law – Equation describing the flow of a fluid through a porous medium Frost flower – Thin layer of ice extruded from a plant Frost heaving – Upwards swelling of soil during freezing Hindu milk miracle – 1995 alleged miracle incidentsPages displaying short descriptions of redirect targets Krogh model Porosimetry – Measurement and characterization of the porosity of a material Needle ice – Ice column formed when liquid groundwater rises into freezing air Surface tension – Tendency of a liquid surface to shrink to reduce surface area Washburn's equation – Equation describing the penetration length of a liquid into a capillary tube with time Young–Laplace equation – Describing pressure difference over an interface in fluid mechanics

Sources: en.wikipedia.org

Supporting material

When carbon dioxide dissolves in water, it forms carbonate and mainly bicarbonate (HCO3–), which causes ocean acidification as atmospheric CO2 levels increase. Carbon dioxide is 53% denser than dry air, but is long-lived and thoroughly mixes in the atmosphere. About half of excess CO2 emissions to the atmosphere are absorbed by land and ocean carbon sinks. These sinks can become saturated and are volatile, as decay and wildfires result in the CO2 being released back into the atmosphere. CO2, or the carbon it holds, is eventually sequestered (stored for the long term) in rocks and organic deposits like coal, petroleum and natural gas.

=== Pharmacodynamics === Mestanolone is an AAS, with both androgenic and anabolic effects. It is very similar in its effects to androstanolone (dihydrotestosterone; DHT), and can be thought of as an orally active version of this AAS. Due to inactivation by 3α-hydroxysteroid dehydrogenase (3α-HSD) in skeletal muscle, mestanolone is described as a very poor anabolic agent, similarly to androstanolone and mesterolone. As mestanolone is 5α-reduced, it cannot be aromatized and hence has no propensity for estrogenic side effects such as gynecomastia. The drug also has no progestogenic activity. Like other 17α-alkylated AAS, mestanolone is hepatotoxic.

After the resignation of Labour MP Marsha Singh due to ill health, Galloway returned to parliament at the March 2012 Bradford West by-election in an unexpected landslide result, with Galloway calling it "the most sensational victory in British political history." His 36% swing, defeating the Labour candidate Imran Hussain, was amongst the largest in modern British political history. Jeremy Corbyn, then a backbench Labour MP, congratulated him in a tweet. Galloway described the result as a "Bradford spring" (after the Arab Spring) and said that it showed the "total rejection" by voters of the three leading political parties. The election campaign was marked by controversy, in particular over the role of sectarianism, Baradari (clan) networks, and allegations about rivals' lack of "Islamic values" Andrew Gilligan noted in The Daily Telegraph that Galloway had won in wards with a predominantly white electorate as well as those with a majority Muslim population. Nick Robinson, the BBC's political editor, believed it was "a one-off political coup by a political one-off" in a seat which has not followed national trends in the past. The novelist Howard Jacobson in The Independent wrote that Galloway's "campaign shamelessly courted Muslim prejudice in smaller matters such as alcohol – where Galloway painted himself as more Muslim than the Muslim Labour candidate whom he accused of liking, shock horror, a tipple." Patrick Cockburn in The Independent on Sunday commented: "It says something about the comatose nature of British politics that an effective critic of ...

=== Bisulfite Treatment === Genomic DNA of interest is treated with sodium bisulfite, which introduces methylation-dependent sequence differences. During sodium bisulfite treatment, unmethylated cytosine residues are converted to uracil, while methylated cytosine residues are unaffected.

Sources: en.wikipedia.org

Notes from published material

"Catholic conservatives in the Weimar Republic: the politics of the Rhenish-Westphalian aristocracy, 1918–1933." German History 18.1 (2000): 60-85. Kohler, Eric D. "The Successful German Center-Left: Joseph Hess and the Prussian Center Party, 1908–32." Central European History 23.4 (1990): 313-348. Lutz, Ralph Haswell. "The Collapse of German Democracy under the Brüning Government March 30, 1930–May 30, 1932." Pacific Historical Review (1941) 10#1: 1-14. online Ross, Ronald J. "Critic of the Bismarckian Constitution: Ludwig Windthorst and the Relationship Between Church and State in Imperial Germany," Journal of Church & State (1979) 21#3 pp 483–506. online Ross, Ronald J. Beleaguered Tower: The Dilemma of Political Catholicism in Wilhelmine Germany (1976), Zeender, John. "Ludwig Windthorst, 1812-1891," History (1992) 77#290 pp 237–54 online Zeender, John K. "The German Center Party, 1890-1906." Transactions of the American Philosophical Society (1976) 66#1 pp 1–125.

Quantum wires, which confine electrons or holes in two spatial dimensions and allow free propagation in the third. Quantum wells, which confine electrons or holes in one dimension and allow free propagation in two dimensions.

On 4 March, at the Extraordinary Arab Summit in Cairo on Developments in the Palestinian Issue, Arab leaders adopted a $53 billion plan proposed by Egypt that did not involve displacing Palestinians from the Strip. The plan was to create an interim committee of "independent, professional Palestinian technocrats" to govern Gaza to prepare for the Palestinian Authority’s return. Hamas said that it would not bring its own candidates to the proposed governing committee but that it would need to give its permission in regards to the committee’s tasks, members and agenda. Mahmoud Abbas said that he would be prepared to hold elections, which Hamas welcomed. The summit released an AI-enhanced presentation showing modern housing developments, as well as blueprints for resorts and attractions. The plan was to seek international funding. The plan outlines a six-month phase of recovery providing temporary housing for 1.5 million displaced Palestinians within seven sites in Gaza, followed by a two-stage reconstruction program: a two-year first stage of $20 billion and a 2.5 year second stage of $30 billion. The New York Times reported the funding for the plan remains unclear as Gulf states will be reluctant to invest in rebuilding Gaza only to see it destroyed again if violence returns. The Israeli foreign ministry said the plan had "outdated" outlooks and rejected the plan's dependence on the Palestinian Authority, adding that Hamas would be given power by the plan.

The following is a partial list of the "D" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM). This list continues the information at List of MeSH codes (D05). Codes following these are found at List of MeSH codes (D08). For other MeSH codes, see List of MeSH codes. The source for this content is the set of 2006 MeSH Trees from the NLM.

Such a molecule might be extracted from a natural product or even be a drug on the market which could be improved upon (so-called "me too" drugs). Other methods, such as virtual high throughput screening, where screening is done using computer-generated models and attempting to "dock" virtual libraries to a target, are also often used. Another method for drug discovery is de novo drug design, in which a prediction is made of the sorts of chemicals that might (e.g.) fit into an active site of the target enzyme. For example, virtual screening and computer-aided drug design are often used to identify new chemical moieties that may interact with a target protein. Molecular modelling and molecular dynamics simulations can be used as a guide to improve the potency and properties of new drug leads. There is also a paradigm shift in the drug discovery community to shift away from HTS, which is expensive and may only cover limited chemical space, to the screening of smaller libraries (maximum a few thousand compounds). These include fragment-based lead discovery (FBDD) and protein-directed dynamic combinatorial chemistry. The ligands in these approaches are usually much smaller, and they bind to the target protein with weaker binding affinity than hits that are identified from HTS. Further modifications through organic synthesis into lead compounds are often required. Such modifications are often guided by protein X-ray crystallography of the protein-fragment complex.

Sources: en.wikipedia.org

Frequently asked questions

What is semax derived from?

Semax is based on the ACTH(4-10) fragment, a seven-amino-acid segment of adrenocorticotropic hormone. The synthetic peptide retains the core sequence while removing regions associated with endocrine activity. This modification is intended to isolate effects on the nervous system.

Is semax approved as a medicine?

It is registered for clinical use in Russia and a few other countries, typically as a nasal drop formulation. It does not hold approval from the United States Food and Drug Administration or the European Medicines Agency. Outside those markets it is generally handled as a research chemical.

Why is much of the research published in Russian?

The compound was developed in Moscow and the earliest studies were conducted there, so the primary literature is largely in Russian-language journals. Translation and indexing have been incomplete, which limits access for outside researchers. Independent groups have since published some work, but the total volume remains modest.

Semax 是天然存在的物质吗?

不是。Semax 是完全人工合成的七肽,自然界中没有对应的已知肽段。它的设计灵感来自促肾上腺皮质激素片段 ACTH(4-10),但序列经过了替换和延长。

Network